πŸ‡ΊπŸ‡Έ FDA
Patent

US 8337896

Drug-containing nanoparticles

granted A61KA61K31/4439A61K9/5153

Quick answer

US patent 8337896 (Drug-containing nanoparticles) held by Takeda Pharmaceutical Company Limited expires Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Dec 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4439, A61K9/5153, A61K9/5161, A61P